ArticleNature communications2022

Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors.

Peitao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.